Arcturus Therapeutics
ARCT
#8612
Rank
NZ$0.31 B
Marketcap
NZ$11.25
Share price
0.78%
Change (1 day)
-57.36%
Change (1 year)

Earnings for Arcturus Therapeutics (ARCT)

Earnings in 2025 (TTM): -NZ$0.14 Billion

According to Arcturus Therapeutics 's latest financial reports the company's current earnings are NZ$85.14 Million. In 2024 the company made an earning of -NZ$0.17 Billion a decrease over its 2023 earnings that were of -NZ$47.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arcturus Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.14 Billion-18.59%
2024 -NZ$0.17 Billion240.24%
2023 -NZ$47.09 Million-298.78%
2022 NZ$23.68 M-106.79%
2021 -NZ$0.35 Billion181.83%
2020 -NZ$0.13 Billion183.72%
2019 -NZ$43.65 Million16.93%
2018 -NZ$37.33 Million154.5%
2017 -NZ$14.67 Million-65.36%
2016 -NZ$42.35 Million25.93%
2015 -NZ$33.63 Million-41.04%
2014 -NZ$57.03 Million219.64%
2013 -NZ$17.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NRC Health
NRC
NZ$47.86 M-136.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-NZ$3.76 Million-97.12% Bahamas